García-García, Teresa
Carmona-Bayonas, Alberto
Jimenez-Fonseca, Paula
Jara, Carlos
Beato, Carmen
Castelo, Beatriz
Mangas, Montserrat
de Castro, Eva Martínez
Ramchandani, Avinash
Gomez, David
Calderón, Caterina https://orcid.org/0000-0002-6956-9321
Funding for this research was provided by:
FSEOM-Onvida for Projects on Long Survivors and Quality of Life. SEOM (Spanish Society of Medical Oncology) 2015. (FSEOM 2015)
Article History
Received: 31 October 2018
Accepted: 12 November 2019
First Online: 26 November 2019
Ethics approval and consent to participate
: The study has been performed in accordance with the ethical standards of the 1964 Declaration of Helsinki and its later amendments. The 15 participating centers (1.HSL/2.HUMM/3.HUCA/4.HUFA/5.HUMV/6.HULPaz/7.HULPrincesa/8.HUIGC/9.HUT/10.HUVM/11.CU-HVL/12.HSCSP/13.HUSE/14.HUS/15.CAS) had institutional review board approval, and all patients consented. The protocol was approved by the Ethics Committee of each hospital and the Spanish Medicines and Health Products Agency (AEMPS). The study was conducted in accordance with the guidelines of Strengthening the Reporting of Observational studies in Epidemiology (STROBE). For human samples, all participants signed consent forms prior to inclusion in the study. This study is an observational trial without intervention.
: Not applicable.
: All authors declare that they have no conflict of interest. This is an academic study.